T. Rowe Price Capital Appreciation Fund
T. Rowe Price Capital Appreciation Fund reported 72 holdings worth US$70.4B as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 27, 2026
T. Rowe Price Capital Appreciation Fund reported 72 holdings worth US$70.4B as of Jun 30, 2026. Largest: Alphabet Inc (google) Class C, Amazon.com, Inc. and Microsoft Corp. Filed Aug 27, 2026 (Form N-PORT).
- Holdings
- 72
- Value as reported
- US$70.4B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Alphabet Inc (google) Class C | 8.1M | US$2.9B | 4.1% |
| Amazon.com, Inc. | 9.85M | US$2.35B | 3.3% |
| Microsoft Corp. | 6.2M | US$2.31B | 3.3% |
| Nvidia Corporation | 9.47M | US$1.9B | 2.7% |
| Broadcom Inc. | 4.7M | US$1.77B | 2.5% |
| Centerpoint Energy, Inc (holding Co) | 40.1M | US$1.76B | 2.5% |
| Meta Platforms, Inc. | 3.1M | US$1.75B | 2.5% |
| Advanced Micro Devices Inc | 2.22M | US$1.29B | 1.8% |
| Revvity, Inc. | 11.4M | US$1.27B | 1.8% |
| Cencora, Inc. | 4.44M | US$1.26B | 1.8% |
| Apple Inc | 3.96M | US$1.15B | 1.6% |
| Aurora Innovation, Inc. | 162M | US$1.1B | 1.6% |
| Mastercard Incorporated | 2.05M | US$1.05B | 1.5% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | 12.7M | US$1B | 1.4% |
| Ascendis Pharma A/s | 3.36M | US$897M | 1.3% |
| Nisource Inc | 17.6M | US$837M | 1.2% |
| Ameren Corporation | 7.16M | US$809M | 1.1% |
| Waters Corporation | 2.1M | US$788M | 1.1% |
| Danaher Corporation | 4.1M | US$781M | 1.1% |
| Micron Technology, Inc. | 630K | US$728M | 1.0% |
| Ppl Corporation | 18.8M | US$684M | 0.97% |
| Visa Inc. | 1.94M | US$665M | 0.94% |
| Alnylam Pharmaceuticals, Inc. | 2.03M | US$613M | 0.87% |
| Doordash, Inc. | 3.2M | US$590M | 0.84% |
| Cytokinetics, Incorporated | 6.29M | US$536M | 0.76% |
| Arista Networks, Inc. | 3.14M | US$534M | 0.76% |
| Keurig Dr Pepper Inc. | 15.9M | US$522M | 0.74% |
| Yum! Brands, Inc. | 3.13M | US$500M | 0.71% |
| Ingersoll Rand Inc. | 6.06M | US$497M | 0.71% |
| Canadian Natural Resources Limited | 12.1M | US$479M | 0.68% |
| Ptc Inc. | 4.19M | US$477M | 0.68% |
| Starbucks Corporation | 4.3M | US$440M | 0.62% |
| Lockheed Martin Corporation | 842K | US$429M | 0.61% |
| Asml Holding Nv | 220K | US$363M | 0.52% |
| Veralto Corp | 4.07M | US$361M | 0.51% |
| Msci Inc. | 605K | US$339M | 0.48% |
| Kkr & Co. Inc. | 3.56M | US$327M | 0.46% |
| Becton, Dickinson And Company | 2.01M | US$305M | 0.43% |
| Northrop Grumman Corporation | 597K | US$304M | 0.43% |
| Hca Healthcare, Inc. | 778K | US$303M | 0.43% |
| Te Connectivity Plc | 1.37M | US$277M | 0.39% |
| Cadence Design Systems, Inc. | 718K | US$269M | 0.38% |
| Jp Morgan Chase & Co. | 783K | US$256M | 0.36% |
| Synopsys, Inc. | 567K | US$253M | 0.36% |
| Kymera Therapeutics, Inc. | 2.05M | US$235M | 0.33% |
| Vaxcyte, Inc. | 4.01M | US$233M | 0.33% |
| Conocophillips | 1.92M | US$199M | 0.28% |
| Ares Management Corporation | 1.67M | US$186M | 0.26% |
| Cg Oncology, Inc. | 2.57M | US$183M | 0.26% |
| Woodward, Inc. | 374K | US$159M | 0.23% |
| Denali Therapeutics Inc. | 4.97M | US$128M | 0.18% |
| Erasca, Inc. | 6.95M | US$127M | 0.18% |
| Chevron Corporation | 765K | US$127M | 0.18% |
| Bentley Systems, Incorporated | 4.12M | US$123M | 0.18% |
| Unitedhealth Group Incorporated | 295K | US$123M | 0.17% |
| Madison Square Garden Sports Corp. | 206K | US$82.8M | 0.12% |
| Xenon Pharmaceuticals Inc. | 1.27M | US$76.9M | 0.11% |
| Dyne Therapeutics, Inc. | 3.28M | US$72.8M | 0.10% |
| Arxis, Inc. | 1.51M | US$69.6M | 0.10% |
| Moonlake Immunotherapeutics | 1.61M | US$31.4M | 0.04% |
| Maze Therapeutics, Inc. | 978K | US$29.2M | 0.04% |
| Cerebras Systems Inc. | 93,589 | US$20.7M | 0.03% |
| Eli Lilly And Company | 0 | US$0 | 0.00% |
| Kla Corporation | 0 | US$0 | 0.00% |
| Netflix, Inc. | 0 | US$0 | 0.00% |
| Abbott Laboratories | 0 | US$0 | 0.00% |
| Ge Aerospace | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Slb Limited | 0 | US$0 | 0.00% |
| Ciena Corporation | 0 | US$0 | 0.00% |
| S&p Global Inc. | 0 | US$0 | 0.00% |
| Workday, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related